Accelerating the Discovery, Translation & Large-Scale Manufacturing of Exosomes & EVs
With 3 days of unrivaled content and two dedicated tracks, this year’s summit will be putting the spotlight on cutting-edge strategies from discovery, translation, and clinical development of modified and unmodified exosomes and EVs, to accelerate this emerging field forward.
Built with biopharmaceutical industry insights, this in-person conference will delve into different types of extracellular vesicles (EVs) from various cell sources as a solution to deliver treatments safely and effectively. Learn how to optimize your translational route towards safe and effective clinical development in a broad range of diseases.
Whether you are challenged by characterization, scale-up manufacturing or regulatory considerations of your EVs or simply are looking to optimize your translational route towards safe and effective clinical development, you will find this year’s summit your one-stop shop to gain meaningful insights and cutting-edge data.
Tailor-made to showcase the latest innovations and interactively discuss the industry’s most important talking points, join 130+ movers and shakers of the field from the likes of Codiak BioSciences, Rion, MDimmune and Aruna Bio at this must-attend summit to successfully optimize, accelerate and scale your extracellular vesicle-based therapeutics towards the first clinical approval.
Download the Full Event Guide here for speakers, presentations, pricing and more.
This post was originally published on Source Link